Concepedia

David J. Ponting

DJ

Statistics

Publications

22

Citations

740

H-Index

17

Active since

2014

Affiliations

Merck (Germany)(Current)

University of Gothenburg

Pfizer (United States)

Gilead Sciences (United States)

AstraZeneca (United Kingdom)

David J. Ponting is an author at Merck (Germany) specializing in pharmacology, medicine, and toxicology.

ORCID

Top concepts

Publications per year

2014–2024

22

Publications

22

The Landscape of Potential Small and Drug Substance Related Nitrosamines in Pharmaceuticals

Joerg Schlingemann, Michael J. Burns, David J. Ponting et al. · Journal of Pharmaceutical Sciences · 2022 · 115 citations · Full text

Developing structure-activity relationships for N-nitrosamine activity

Kevin P. Cross, David J. Ponting · Computational Toxicology · 2021 · 92 citations · Full text

The Nitrosamine “Saga”: Lessons Learned from Five Years of Scrutiny

Raphael Nudelman, Grace Kocks, Bruno Mouton et al. · Organic Process Research & Development · 2023 · 68 citations · Full text

, , +17

What Makes a Potent Nitrosamine? Statistical Validation of Expert-Derived Structure–Activity Relationships

Robert Thomas, Rachael E. Tennant, Antonio Anax Falcão de Oliveira et al. · Chemical Research in Toxicology · 2022 · 54 citations · Full text

Mechanisms of Nitrosamine Mutagenicity and Their Relationship to Rodent Carcinogenic Potency

David J. Snodin, Alejandra Trejo‐Martin, David J. Ponting et al. · Chemical Research in Toxicology · 2024 · 42 citations

, , +17

1–5 of 22